Netocta Lar Octreotide Long Active Release Injection

Link Copied

13,700.00 / Box

10 Box (MOQ)

Edit

Business Type	Manufacturer, Exporter, Supplier, Trader
Medicine Type	Anti Cancer
Brand Name Available	Netocta Lar / Netvica Lar/sandostatin Lar / Bd Octerio
Strength Available	20mg & 30mg
Click to view more

Product Details

Form

Injection

Treatment

Severe Diarrhea and other Symptoms that Occur with Certain Intestinal Tumors

Composition

Octreotide Long Acting Release

Country of Origin

Made in India

Prescription/Non Prescription

Prescription

Storage

2 to 8 Degree

Shelf Life

24 Month

Packaging Type

Box

Octreotide long-acting injection is used to control acromegaly, carcinoid tumors, and VIP-omas in people who have been successfully treated with octreotide injection but prefer to receive injections less often.
Octreotide LAR is approved for treatment of acromegaly after surgery if the disease is not controlled. This study was aimed to test the safety and efficacy of octreotide LAR in acromegalic patients who did not have any previous treatment for acromegaly.
Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or VIPomas) or metastatic carcinoid tumors (tumors that has already spread in the body). It does not cure the tumor but it helps the patient feel more comfortable.